Surely their risk aversion in the past ensured that we had low debt and a growing income, putting us on very solid and prudently managed foundations. Just compare it to some of the other companies in the sector if you want to see what cowboys can do.
I think if they needed to take on a bit of debt it would be easily handled and the c.o.s. with rising earnings is looking almost a done deal, almost I say. Overall I see them as a prudently managed company compared to many others in the sector and I remain as an accumulator of PNV shares. We all have our own opinions and rightly so. Discussions in here give us all a better chance to fill out the broad canvas of PNV and can help us to have a better chance see the wider views of our company.
- Forums
- ASX - By Stock
- PNV
- Ann: 1H FY22 Results Presentation
Ann: 1H FY22 Results Presentation, page-331
-
-
- There are more pages in this discussion • 178 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.39 |
Change
-0.040(1.65%) |
Mkt cap ! $1.650B |
Open | High | Low | Value | Volume |
$2.41 | $2.46 | $2.39 | $3.298M | 1.372M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 46456 | $2.39 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.42 | 7428 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 46456 | 2.390 |
5 | 15357 | 2.380 |
5 | 12193 | 2.370 |
2 | 3724 | 2.360 |
6 | 38474 | 2.350 |
Price($) | Vol. | No. |
---|---|---|
2.420 | 7428 | 2 |
2.430 | 11209 | 5 |
2.440 | 7428 | 2 |
2.450 | 1724 | 1 |
2.460 | 37724 | 4 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online